Monday, 10 December, 2018

Stock You May Need To Reconsider: Berkshire Hathaway Inc. (BRK-B)

Bloomberg’s Tom Giles reports on Buffett’s decision to cut Berkshire’s stake in Big Blue by 94 percent Bloomberg’s Tom Giles reports on Buffett’s decision to cut Berkshire’s stake in Big Blue by 94 percent
Nellie Chapman | 16 February, 2018, 02:44

During the fourth quarter, Berkshire bought more than 31.2 million shares of Apple, and although we don't know the exact price Berkshire paid, based on the tech giant's share price during the quarter, it's likely that the company spent upwards of $5 billion.

Charlie Munger, the 94-year-old vice chairman of Warren Buffett's Berkshire Hathaway, called bitcoin "noxious poison," saying "the more popular it got, the more [he] hated it". Not our assessment. Cramer, who also hosts Mad Money on the same network, needed to understand the reasoning behind the $358 million investment by the "Oracle of Omaha".

Even after rebounding a bit, Teva is still down 39% from a year ago - even after the after-hours "Buffett rally". In an interview with Calcalist held last week Teva's Chief Financial Officer Michael McClellan said the company had a "fairly good" quarter. "I'm all for somebody trying to figure it out". That is a coalition that could rely on generics to bring down [drug] pricing.

Warren Buffett. Image source: The Motley Fool.

"I think it's time for regulators to let up on Wells Fargo".

"No, he does not", replied Faber. Us Bancorp is 2.97% of its portfolio. The investment in Apple represents an investment in an innovative technology company that is changing the way numerous world's people consume, and that has strong management, led by Tim Cook. "Credit rating downgrades. A bad [decision to] purchase the generics business from Allergen". "It worked well for a long time until it didn't". Bitcoin can only be used as a medium of exchange and in practice has been far more important for the dark economy than it has for most legitimate uses. "Employment-they've had to cut a lot of jobs, which is anathema in that country". The stock closed up $3.03 today at $167.37.

Berkshire Hathaway and Phillips 66 said this repurchase will let Buffett's company to reduce its investment below the 10 percent level that triggers additional regulations.

"Buffett's investment in Teva's share indicates his confidence in Teva's new CEO, Kare Schultz, and in his ability to succeed in the company's large-scale restructuring plan, after having already succeeded in a major streamlining effort at Danish company Lundbeck, "Bank of Jerusalem (TASE: JBNK) head of global trading desk and FX Ilan Sterk says". With about 1.9 percent of Teva's US -traded shares, Berkshire became the tenth-biggest shareholder in the world's largest manufacturer of generic medicines. Teva has recently joined the cannabis race with a product created to treat pain using cannabis administered through an inhaler.

Meanwhile, Wall Street analysts offered positive and negative data points about the health of Apple's business on Thursday.